 9. If treated with systemic glucocorticoidcorticosteroid medications, no dose changes in the previous two months before randomization, or anticipated dose changes throughout the study duration; the dosing regimen should be consistent with maintenance therapy i.e. not for an acute or active uncontrolled disease as determined by the investigator. Note: this criteria does not pertain to inhaled andor topical glucocorticoidcorticosteroid therapies 